Nuveen’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Nuveen’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-27,406	Closed	-$1.45M	–	3389
2020 Q3	$1.45M	Buy	27,406 +4,475	+20%	+$276K	﹤0.01%	2511
2020 Q2	$1.41M	Sell	22,931 -3,163	-12%	-$183K	﹤0.01%	2475
2020 Q1	$1.48M	Sell	26,094 -3,567	-12%	-$203K	﹤0.01%	2339
2019 Q4	$1.69M	Sell	29,661 -18,318	-38%	-$971K	﹤0.01%	2493
2019 Q3	$2.57M	Sell	47,979 -23,304	-33%	-$1.36M	﹤0.01%	2289
2019 Q2	$4.26M	Buy	+71,283	New	+$4.49M	﹤0.01%	2075

Other funds holding BSTC

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Nuveen's BSTC Position: Q4 2020 in Review

Nuveen sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 27,406 shares — an estimated $1.45M sold.

Nuveen first reported a position in BSTC in Q2 2019 and held it in 6 quarters. The position peaked at $4.26M in Q2 2019. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.

Nuveen reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
Nuveen sold 27,406 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $1.45M.
Nuveen first reported a position in BioSpecifics Technologies Corp. in Q2 2019 and held it in 6 quarters.
Nuveen's BioSpecifics Technologies Corp. position peaked at $4.26M in Q2 2019.
1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.

Based on Nuveen's 13F filing for Q4 2020, filed 16 Feb 2021.